|
|
|
| Relationship between breast hyperplasia and breast cancer from the ancient literatures of Ming and Qing Dynasties |
| LUO Runjia1 WANG Xingyu1 XU Qianqian2 SUN Xue2 LI Jingwei3 |
1.The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Shandong Province, Ji’nan 250014, China;
2.College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Shandong Province, Ji’nan 250014, China;
3.Department of Breast and Thyroid Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong Province, Ji’nan 250014, China |
|
|
|
Abstract Traditional Chinese medicine surgery has developed and matured in Ming and Qing Dynasties, the understanding of breast disease reaches a new height. It is found that there is a correlation between breast hyperplasia and breast cancer, but modern medicine also believes that the occurrence of breast cancer is related to breast hyperplasia. Based on the analysis of famous doctors and their works in Ming and Qing Dynasties, this paper discusses the relationship between breast hyperplasia and disease name, etiology and pathogenesis, clinical manifestations, treatment principles and methods of breast cancer. The nomenclature of disease is closely related to symptoms and signs, and emotional factors are the main causes of both diseases. Both liver and spleen injury and thoroughfare-controlling vessels disharmony are the common pathogenesis, clinical manifestation of breast tuberculosis is a common symptom, with the further progress of the disease, the difference gradually show up. The key to treat the mastophilia and lactolith is to dredge liver and regulate qi, replenish qi and blood, and pay attention to emotional adjustment.
|
|
|
|
|
|
[1] Li HT，Liu HH，Yang YX，et al. Therapeutic effects of a traditional Chinese medicine formula plus tamoxifen vs. tamoxifen for the treatment of mammary gland hyperplasia：a meta-analysis of randomized trials [J]. Front Pharmacol，2018，9：45.
[2] Bray F，Ferlay J，Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries，2018 [J]. CA Cancer J Clin，2018，68（6）：394-424.
[3] Cote ML，Ruterbusch JJ，Alosh B，et al. Benign breast disease and the risk of subsequent breast cancer in African American women [J]. Cancer Prev Res（Phila），2012，5（12）：1375-1380.
[4] 王桂玲，任连成，刘春香.乳腺增生与乳腺癌相关性研究[J].中国医药导刊，2014，16（6）：972-973.
[5] 华佗.中藏经[M].北京：人民卫生出版社，2007：95.
[6] 龚居中.外科活人定本[M].北京：中国中医药出版社，2015：70.
[7] 高秉钧.疡科心得集[M].北京：中国中医药出版社，2000：63.
[8] 陈自明.妇人大全良方[M].南昌：江西人民出版社，1983：450.
[9] 李曰庆.中医外科学[M].北京：中国中医药出版社，2011：113.
[10] 沈金鳌.杂病源流犀烛[M].北京：中国中医药出版社，1994：215.
[11] 祁坤.外科大成[M].上海：上海卫生出版社，1957：25-28.
[12] 王旭高.外科证治秘要[M].北京：中医古籍出版社，2005.
[13] 罗国纲.罗氏会约医镜[M].北京：人民卫生出版社，1965：564.
[14] 陈实功.外科正宗[M].天津：天津科学技术出版社，1993：67-162.
[15] 潘吉甫.近代中医珍本集·潘氏外科秘本九种·疡症歌诀[M].杭州：浙江科学技术出版社，2003：547.
[16] 邹五峰.外科真诠[M].上海：上海中医书局，1955：110-112.
[17] 申斗垣.外科启玄[M].北京：人民卫生出版社，1955：37.
[18] 王维德.外科证治全生集[M].北京：中国中医药出版社，1996.
[19] 许克昌，毕法.外科证治全书[M].北京：人民卫生出版社，1987.
[20] 余听鸿.外证医案汇编[M].上海：上海科学技术出版社，2014：158-170.
[21] 顾世澄.疡医大全[M].北京：人民卫生出版社，1987：757-763.
[22] 赵文静，旺建伟，隋方宇，等.乳腺增生病与乳腺癌病因相关性研究[J].中医药学报，2015，43（3）：28-30.
[23] 吴谦.医宗金鉴·外科心法要诀[M].北京：人民卫生出版社，1982：233.
[24] 黄帝内经·素问[M].北京：人民卫生出版社，1978.
[25] 张介宾.景岳全书（下册）[M].上海：上海科学技术出版社，1959：955.
[26] 高文晋.外科图说[M].上海：大魁桢记，1856.
[27] 马培之.马培之外科医案[M].上海：中医书局，1955：34-37.
[28] 戴金芳，赵益，孙有智.乳腺癌中医病因病机探析[J].光明中医，2017，32（7）：1069-1072.
[29] 朱橚.普济方（第八册）[M].北京：人民卫生出版社，1959：234.
[30] 马薇，金泉秀，吴云飞，等.乳腺增生症诊治专家共识[J].中国实用外科杂志，2016，36（7）：759-762.
[31] 王肯堂.证治准绳4疡医[M].北京：人民卫生出版社，1993：484.
[32] 吴谦.医宗金鉴[M].北京：人民卫生出版社，2006：845.
[33] 高思敬.外科医镜[M].北京：人民军医出版社，2005：16-105.
[34] 薛己.薛氏医案选·外科枢要[M].北京：人民卫生出版社，1938：128-129.
[35] 李梴.医学入门[M].北京：中国中医药出版社，1995：474.
[36] 张路玉.张氏医通[M].上海：上海书局石印，1907.
[37] 傅山.青囊秘诀[M].太原：山西人民出版社，1983：46.
[38] 无名氏.医方辨难大成[M].上海：上海中医药大学出版社，2006. |
|
|
|
